Laurion Capital Management LP Vaxart, Inc. Transaction History
Laurion Capital Management LP
- $5.37 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding VXRT
# of Institutions
28Shares Held
4.41MCall Options Held
0Put Options Held
0-
Marshall Wace, LLP London, X01.95MShares$800,7450.0% of portfolio
-
Black Rock Inc. New York, NY1.77MShares$727,4810.0% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL188KShares$77,2370.0% of portfolio
-
Xtx Topco LTD London, X094.3KShares$38,6450.0% of portfolio
-
Hbk Sorce Advisory LLC Erie, PA75.1KShares$30,7980.0% of portfolio
About Vaxart, Inc.
- Ticker VXRT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 126,506,000
- Market Cap $51.9M
- Description
- Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...